Yahoo Finance reporter Alexis Keenan talks with Mike Erbeck, United Airlines, VP at Newark Airport about the safety measures they are taking during the coronavirus pandemic to protect customers.
...
IBM Corp. (IBM) has signed an agreement to buy Spanugo, a US-based provider of cybersecurity solutions, to help meet the security demands of its public cloud business.The terms of the deal were not disclosed. IBM said that it will integrate the Spanugo software into its public cloud to support stringent safety requirements of its clients in highly regulated industries. Shares rose 2.4% to $124.62 in pre-market trading.At the end of last year, IBM said that it was building a financial services-specific public cloud, the first of its kind, to help address the requirements of institutions, such as banks, for regulatory compliance, security and resiliency.The Spanugo software will provide preventative and compensatory controls for financial services regulatory workloads, proactive and automated security, leveraging the industry's highest levels of encryption certification. The software includes a security control center that will enable IBM clients to define compliance profiles, manage controls and, in real time,...
Acadia Pharmaceuticals Inc. (ACAD) has announced that it has filed a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) to support a potential new indication for Nuplazid (pimavanserin) for the treatment of hallucinations and delusions associated with dementia-related psychosis (DRP).The FDA previously granted Breakthrough Therapy Designation for pimavanserin for this indication.“This is an important step forward for the approximately 2.4 million people in the U.S. who suffer from dementia-related hallucinations and delusions, representing a large unmet need with currently no approved treatment options,” said Steve Davis, Acadia’s CEO.The application follows ACAD’s pivotal Phase 3 HARMONY study, which met its primary endpoint, demonstrating that pimavanserin significantly reduced the risk of relapse of psychosis by 2.8 fold compared to placebo.The sNDA also includes positive efficacy results from two additional placebo-controlled studies, both of which met their respective primary endpoints, and a large safety and tolerability database of over 1500 patients.Dementia affects approximately...
(Bloomberg) -- Banks including Credit Suisse Group AG and Morgan Stanley face a $300 million shortfall on margin loans to the embattled founder of Luckin Coffee Inc.The lenders, which also include Haitong International Securities Group and Goldman Sachs Group Inc., raised about $210 million over the past two months selling Luckin shares that Chairman Lu Zhengyao had pledged as collateral, people familiar with the matter said. Lu defaulted on $518 million of margin debt in early April, Goldman said in a statement at the time, after revelations of accounting fraud caused the Chinese coffee chain’s stock to plunge.The share sales represent the latest attempt by Lu’s creditors to limit losses from a scandal that has fueled calls in Washington for tougher scrutiny of financial ties between the U.S. and China. Luckin’s fall from grace blindsided some of the biggest names on Wall Street just as they were gearing up for a...
